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Abstract
Aortic valve calcification without outflow obstruction (stenosis) is common in the elderly and
increases the risk of cardiovascular morbidity and mortality. Although high blood pressure (BP)
measured at the doctor’s office is known to be associated with aortic valve calcification, little is
known about the association between 24-hour ambulatory BP (ABP) and aortic valve calcification.
Our objective was to clarify the association between ABP variables and aortic valve calcification.
The study population consisted of 737 patients (mean age 71±9 years) participating in the
Cardiovascular Abnormalities and Brain Lesions (CABL) study who underwent 24-hour ABP
monitoring. Each aortic valve leaflet was graded on a scale of 0 (normal) to 3 (severe
calcification). A total valve score (values 0–9) was calculated as the sum of all leaflets’ score.
Advanced aortic valve calcification (score ≥4) was present in 77 subjects (10.4%). All systolic
ABP variables (except systolic BP nocturnal decline) and mean asleep diastolic BP were
positively associated with advanced calcification, while normal dipping status and diastolic BP
nocturnal decline were negatively associated. Multiple regression analysis indicated that mean
awake diastolic BP (OR 1.31, 95% CI 1.01–1.71) and asleep diastolic BP (OR 1.34, 95% CI 1.04–
1.72) remained independently associated with advanced calcification after adjustment for age, sex,
cigarette smoking, diabetes mellitus, hypercholesterolemia, hypertension, serum creatinine, and
any degree of aortic insufficiency. Diastolic ABP is independently associated with advanced
calcification. This finding may have important implications in gaining further insight into the
mechanism of aortic valve calcification.
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Aortic valve calcification (AVC), which is defined as focal areas of increased echogenicity
and thickening of the aortic valve leaflets without any resultant outflow obstruction
(stenosis), is a subclinical abnormality that is common in the elderly1, 2, and has traditionally
been considered a relatively benign degenerative process. However, this view has recently
been challenged, as AVC has been found to be associated with cardiovascular morbidity and
mortality.3 AVC is an active process 4 related to the traditional risk factors for
atherosclerosis, including male sex 5, hypertension 5–8, hypercholesterolemia7, 8, smoking 5,
and diabetes7, 8, as well as hyperparathyroidism.9 Local hemodynamic factors, such as low
shear stress and high tensile stress on the aortic leaflets, can also facilitate endothelial injury
and are associated with early atherosclerotic changes including AVC.10, 11
Ambulatory blood pressure monitoring (ABPM) provides information that is not obtained
from conventional office blood pressure (BP) readings, and is also more reliable and
reproducible than office BP measurements12. Several studies have demonstrated that target
organ damage13, 14 and prognosis15 are more closely associated with ambulatory BP than
with office BP. Moreover, ABPM provides data on possibly reduced nocturnal BP decline
(“non-dipping”) and increased 24-hour BP variability, which are associated with subsequent
cardiovascular events and cardiovascular mortality16, 17. However, the association between
ABPM variables and AVC has not been addressed in a properly sized clinical study.
The aim of the present study was therefore to assess the relationship between AVC and
ABPM variables (24-hour/awake/asleep mean values, variability and nocturnal decline) in
an unselected sample of the general population.
Methods
Study population
This study was conducted at Columbia University Medical Center. The study sample was
derived from the National Institutes of Neurological Disorders and Stroke (NINDS)-
sponsored Cardiovascular Abnormalities and Brain Lesions (CABL) study, whose aim is to
assess the relationship between subclinical cardiovascular disease and silent brain
infarctions in a community-based cohort. Participants in CABL were drawn from the
Northern Manhattan Study (NOMAS), an epidemiologic study carried out in New York
City. Extensive details about the population and enrollment of NOMAS have been published
previously18. Briefly, subjects were eligible if they (1) had never been diagnosed with
stroke, (2) were aged ≥50 years, and (3) resided in northern Manhattan for ≥3 months in a
household with a telephone. Cardiovascular risk factors were ascertained through direct
examination and interviews conducted by trained research assistants. Among the variables
used in the analysis, hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg
or diastolic blood pressure (DBP) ≥90 mmHg (mean of two readings taken in a research
clinic setting) or a patient’s self-reported history of hypertension or antihypertensive
medication use. Diabetes mellitus was defined by the patient’s self-report of history and/or
current use of insulin or hypoglycemic agents, or a fasting glucose of >126 mg/dl, tested on
at least two occasions in each participant. Smoking status was defined as cigarette smoking
at any time in the past or present. Hypercholesterolemia was defined as total serum
cholesterol >240 mg/dl, a patient’s self-report of hypercholesterolemia or use of lipid-
lowering medications.
The study was approved by the institutional review board of Columbia University Medical
Center, and informed consent was obtained from all study participants.
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Detection of aortic valve calcification
Two-dimensional transthoracic images of the aortic valve were obtained by a registered
cardiac sonographer following a standardized protocol with a commercially available system
(iE33; Philips Medical Systems, Andover, MA) equipped with a 2.5-MHz to 3.5-MHz
transducer. All the tests were stored on digital media for subsequent analysis. AVC was
defined as bright dense echoes more than 1 mm in size on one or more cusps19. Each valve
leaflet was graded on a scale of 0 (normal) to 3 (severe calcification). A total valve score
(values 0–9) was calculated as the sum of the scores of all leaflets1. A score ≥4 was defined
as advanced AVC, which means presence of at least one moderate calcified deposit and two
mild calcified deposits in three leaflets (Figure 1). We excluded 18 subjects with bicuspid
aortic valve or aortic stenosis (defined as peak flow velocity ≥ 2.5m/s).
All images were interpreted by a single experienced echocardiographer (SI) blinded to
subject’s characteristics and risk factors.
Ambulatory Blood Pressure Assessment
An ambulatory BP monitor (SpaceLabs Model 90207, Redmond, WA) was used to assess
24-hour BP as the subjects performed their normal activities. The accuracy and reliability of
the device have been previously validated according to the Association for the Advancement
of Medical Instrumentation criteria 20. ABPM was performed according to previously
published protocols with a BP cuff appropriately sized to arm circumference and placed on
the subject’s non-dominant arm. The monitor was set to automatically record BP at 15-
minute intervals during awake hours and 30-minute intervals during sleep hours. Before use,
the device was calibrated against a reference mercury manometer; the criterion for target
agreement was within ± 5 mmHg. Recordings were uploaded, stored, and exported with the
aid of ambulatory BP report management system software (SpaceLabs Systems, 2004). The
mean SBP and DBP obtained by ambulatory BP assessment were calculated for a 24-hour
period and separately for awake and sleep periods, which were determined using subjects’
diary reports of actual sleep and awake times. BP variability was calculated as the SDs of
mean awake and asleep SBP and DBP. The percent nocturnal decline in SBP was calculated
as (awake SBP - asleep SBP) × 100/ awake SBP; nocturnal decline in DBP was similarly
calculated17. The management of the ABPM data and computation of summary measures
was supervised by one of the authors (JES). Office BP was assessed as the average of two
measurements in sitting position taken by a research assistant using a mercury
sphygmomanometer and BP cuff appropriately sized to arm circumference.
Statistical analysis
Continuous variables are expressed as mean value ± SD, categorical variables as
percentages. The distribution of ABPM variables and potential covariates was evaluated in
the overall population and among advanced aortic valve calcification (Score ≥4) versus the
rest (Score ≤3). Comparison between groups was assessed using unpaired Student’s t-test for
continuous variables and the chi-square test or Fisher’s exact test for categorical variables. A
multiple logistic regression analysis was carried out to identify those ABPM variables that
were associated with advanced AVC adjusting for age, male sex, cigarette smoking,
hypercholesterolemia, diabetes mellitus, hypertension, serum creatinine, and any degree of
aortic insufficiency. (model 1). In addition to the above covariates, we adjusted for anti-
hypertensive medication use and anti-hypertensive medication class (model 2), and further
for anti-hypercholesterolemic medication (model 3). We also adjusted for awake/asleep
mean SBP/DBP levels in the analyses involving BP variability, and for 24-hour mean BP in
the analyses involving nocturnal BP decline. A p value of < 0.05 was considered statistically
significant for all tests. Statistical analysis was performed using SAS software version 9.2
(SAS Institute Inc, Cary, NC).
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A total of 1004 participants were enrolled in CABL, but 169 did not have ABPM because of
refusal (n=155) or inability to complete the test (n=14). This left 835 participants with
ABPM data, out of which incomplete information on AVC or insufficient ABPM data points
were observed in 98, leaving a final sample size of 737. The distribution of calcification
score was Score 0 (n=18), Score 1 (n=105), Score 2 (n=389), Score 3(n=148), Score 4
(n=57), Score 5 (n=16), Score 6 (n=3), Score 7 (n=1). Advanced AVC (score ≥4) was
present in 77 subjects (10.4%). Clinical characteristics of the study cohort and ABPM
findings according to the aortic valve calcification score are shown in Table 1. Office SBP,
but not office DBP, tended to be associated with advanced AVC. Age, male sex,
hypertension, serum creatinine, any degree of aortic insufficiency and all SBP variables
(except SBP nocturnal decline, which was of borderline significance) were positively
associated with advanced AVC. Normal dipping status and DBP nocturnal decline were
inversely associated with advanced AVC. Mean asleep DBP was positively associated with
advanced AVC.
ABPM variables associated with advanced AVC - Multivariable analysis
Table 2 shows the ABPM variables associated with the presence of advanced AVC (score
≥4) and their adjusted standardized odds ratio obtained by multiple logistic regression
analysis. Awake SBP were associated with a borderline increase in risk of advanced AVC.
Awake (Odds Ratios 1.31 per 1 standard deviation increase, 95% CI 1.01 to 1.71, p<0.05),
asleep (OR 1.34 per 1 standard deviation increase, 95% CI 1.04 to 1.72, p<0.05), mean DBP
remained independently associated with advanced AVC after adjustment for age, sex,
smoking status, diabetes mellitus, hypercholesterolemia, hypertension, serum creatinine, and
the presence of aortic insufficiency (model 1). Additional adjusted models including anti-
hypertensive medications and their classes (model 2) and anti-hypercholesterolemic
medication use (model 3) did not significantly affect the results, with the exception that 24-
hour mean DBP became significantly associated with advanced AVC in model 3. Nocturnal
BP non-dipping, SBP and DBP variability were not associated with advanced AVC in the
models and when we used the coefficient of variation instead that was not different in results
from SD.
Only 46 subjects had LV ejection fraction less than 50% (41, or 6% in the lower AVC
group; 5, or 7%, in the higher AVC group; P=0.92). Their exclusion from the analyses did
not significantly affect the associations observed.
AVC and BP control—Among hypertensives (N=577), the proportion of advanced AVC
was significantly lower in subjects with better controlled BP by ABPM (daytime mean
SBP≤135 and daytime mean DBP≤85 than in those less well controlled (9.5% vs. 15.9%;
P=0.02).
Discussion
In the present study, we observed that all systolic ABPM variables (except SBP nocturnal
decline) were associated with the presence of advanced AVC. However, only 24-hour/
awake/asleep mean DBP remained significantly associated with advanced calcification after
adjustment for accepted atherosclerotic risk factors. SBP variables and a blunted nocturnal
decline in both systolic and diastolic BP were not found to be associated with advanced
calcification in the multivariable analyses. These results suggest that DBP may be more
important than SBP for early-stage atherosclerotic process in the aortic valve. To the best of
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our knowledge, this is the first study to demonstrate that 24-hour/awake/asleep mean DBP
are associated with advanced AVC in the general population.
AVC without outflow obstruction is a subclinical abnormality that is common in the
elderly1, 2. Once AVC has occurred, it causes less effective stress sharing among the leaflets
and facilitates injury to leaflet endothelial cells 21. In general, this is an irreversible process
that may lead to clinically significant stenosis and consequent poor clinical outcome3, 22,23.
Therefore, the identification of factors involved in the subclinical stages of valve
calcification may provide therapeutic targets to inhibit or slow down the progression
towards aortic stenosis.
There is growing evidence that hypertension is associated with calcific aortic valve
disease1, 6–8. However, most studies on the topic have also included aortic valve stenosis,
making the separate analysis of subclinical valvular abnormalities more difficult or not
feasible. Moreover, no studies to date have explored the separate impact of SBP and DBP on
AVC using 24-hour ABPM values. The finding that subclinical AVC is more strongly
associated with DBP than with SBP may provide insight into the pathogenesis of AVC,
which is not completely understood. Early alterations occur on the aortic side of the leaflet
that is exposed to low shear stress and elevated stretch, suggesting local hemodynamic
factors may be the initiating factors in valvular calcification 24. Shear stress, the drag force
acting on the leaflets that results from blood flow, plays an important role in the
development of endothelial dysfunction and atherosclerosis2511. Shear stress acting along
the endothelium on the aortic side of the leaflet is lower than that on the ventricular side of
the leaflet 25 and influenced by end-diastolic pressure. Aortic cusps are stretched (cyclic
stretch) to overcome backward pressure, i.e. end-diastolic pressure, from the blood in the
aorta during diastole. Elevated cyclic stretch causes matrix remodeling in the aortic valve
leaflets10. DBP, rather than SBP, is assumed to affect the blood flow characteristics on the
aortic side of leaflet, increasing the effects of low shear stress and cyclic stretch.
Consequently, elevated 24-hour/awake/asleep mean DBP may be both the initiating factor of
an atherosclerotic process in the aortic valve and a therapeutic target to slow its progression.
In our study, participants with well controlled ABPM values had significantly less frequency
of advanced AVC, suggesting a role for BP control in preventing advanced AVC.
In our study, 24-hour/awake/asleep mean DBP were associated with AVC, but office DBP
was not. This is consistent with previous studies showing the superiority of ABPM over
office BP in predicting hypertensive vascular damage. A previously published study
conducted in older subjects (mean age of 82.4 years) reported that 24-hour mean SBP, but
not office SBP, was associated with white matter hyperintensity volume, which is a marker
of microvascular brain damage 26. We have previously reported that asleep systolic BP
variability, which can only be obtained from ABPM, is associated with large arch
atherosclerotic plaque in the same study population as the present report9. The mechanisms
behind the different results (SBP associated with aortic atherosclerosis, DBP associated with
aortic valve calcification) are unclear, but may reflect regional differences in the
atherosclerotic process. For example, the aortic valve, which is a mobile structure that
regulates high velocity blood flow, might be more resistant to the effects of shear stress (and
therefore SBP) than to cyclic stretch.
The Oulu Project Elucidating Risk of Atherosclerosis (OPERA) study reported that BP non-
dipping status was associated with carotid intima-media thickness, a marker of early
atherosclerosis27. In our study, neither BP dipping status (a binary variable) nor nocturnal
BP decline (a continuous measure) was associated with AVC. In the same cohort, we
previously showed that BP non-dipping status was not associated with aortic arch
atherosclerosis 9. The role of BP dipping status as a risk factor for early atherosclerosis
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remains to be clarified, and BP non-dipping may not be involved in early valvular
atherosclerotic changes.
Our study has some limitations. First, cross-sectional data cannot provide evidence of
causality. Prospective studies would be necessary to assess whether BP variables indeed
predict progression of aortic calcification to aortic stenosis. Second, given the relatively
small number of advanced calcifications, we could not compare the relationship between BP
and aortic calcification across different race/ethnic groups. Third, although we adjusted our
analyses for the most pertinent variables that may affect aortic valve calcification, our study
was not designed as a case-control, and the possibility exists that some confounding factors
may have been incompletely adjusted for.
Perspectives
Awake, asleep, and 24-hour mean DBP, but not office DBP or any SBP variables, were
independently associated with advanced aortic valve calcification, which carries a greater
risk of cardiac events. This finding implies that DBP may be more important than SBP in the
onset and progression of aortic valve calcification. From a practical standpoint, this finding
supports the hypothesis that tight DBP control may provide clinical benefit for preventing or
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AVC aortic valve calcification
ABPM ambulatory blood pressure monitoring
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• This is the first study to assess the relationship between ABPM variables (24-
hour/awake/asleep mean values, variability and nocturnal decline) and aortic
valve calcification
• This is also the first study to demonstrate that 24-hour/awake/asleep mean DBP
values, but not SBP values, are associated with advanced aortic valve
calcification
What Is Relevant?
• Awake, asleep, and 24-hour mean DBP, but not office DBP, are independently
associated with advanced aortic valve calcification, and may identify individuals
at increased risk
• Lowering DBP values may avoid or delay the progression of AV calcification
towards aortic stenosis
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Awake, asleep, and 24-hour mean DBP but not office DBP or SBP values, are
independently associated with advanced aortic valve calcification. This finding supports
the hypothesis that DBP control may provide clinical benefit in preventing or slowing the
progression of calcified aortic disease.
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Two-dimensional image (parasternal short-axis view) of the aortic valve showing an
example of calcification score determination. The calcification of the non-coronary cusp
(arrow) was graded as severe (score=3) and the calcifications of right and left coronary
cusps (arrowheads) were graded as mild (score=1). The total valve calcification score,
obtained from the sum of the individual scores, was therefore 5.
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Table 1
Baseline characteristics and ABPM according to the aortic valve calcification score
Characteristics Overall population N=737 Calcification Score(≤3) N=660
Calcification Score
(≥4) N=77 P value
Age 71±9 70±9 78±8 <0.0001
Male,% 40% 38% 55% 0.01
Race/ethnicity 0.02
White,% 13% 12% 14%
Black, % 17% 15% 27%
Hispanic,% 71% 72% 58%
Cigarette smoking (ever), % 54% 54% 55% 0.90
Diabetes mellitus, % 30% 29% 31% 0.79
Hypertension, % 78% 77% 88% 0.03
Hypercholesterolemia, % 68% 67% 75% 0.20
Serum creatinine, mg/dl 0.9±0.3 0.9±0.3 1.1±0.5 0.002
Left ventricular mass index, g/m2 103±25 102±25 110±30 0.03
Left atrial dimension, mm 39±5 39±5 42±5 <0.001
Aortic insufficiency (any degree), % 32% 29% 55% <0.001
Moderate or severe aortic insufficiency, % 2% 2% 3% 0.65
Left ventricular ejection fraction, % 63±8 63±8 62±8 0.22
Anti-hypertensive medication use, % 72% 71% 79% 0.14
 ACEI/ARB 18% 15% 22% 0.38
 βblocker 12% 13% 5% 0.06
 Ca blocker 20% 19% 27% 0.18
 Diuretic 14% 13% 21% 0.13
 Other medication 11% 12% 6% 0.21
Anti-hypercholesterolemic medication use, % 57% 55% 72% 0.01
Aspirin use, % 69% 68% 78% 0.06
24 hr mean HR, bpm 71.8±9.1 71.8±9.1 72.0±9.0 0.80
Mean awake HR, bpm 75.1±10.1 75.1±10.2 75.0±9.3 0.94
Mean asleep HR, bpm 65.9±8.9 65.8±8.9 66.8±9.2 0.39
Office SBP, mmHg 135.6±17.5 135.2±17.4 139.2±18.1 0.06
Office DBP, mmHg 78.6±9.4 78.5±9.2 79.3±11.0 0.47
24 hr mean SBP, mmHg 124.7±14.4 124.1±14.4 130.5±12.8 0.002
24 hr mean DBP, mmHg 71.5±8.5 71.3±8.5 72.9±8.7 0.12
SBP nocturnal decline, % 7.4±7.3 7.5±7.4 5.9±6.4 0.07
DBP nocturnal decline, % 10.6±8.3 10.9±8.3 8.3±8.1 0.01
Mean awake SBP, mmHg 128.3±14.7 127.7±14.7 133.5±13.5 <0.001
Mean awake DBP, mmHg 74.3±9.0 74.1±9.0 75.4±9.1 0.23
Mean asleep SBP, mmHg 118.7±16.3 117.9±16.3 125.5±14.8 <0.001
Mean asleep DBP, mmHg 66.3±9.4 66.0±9.3 68.9±10.2 0.01
SBP awake variability, mmHg 12.5±3.4 12.4±3.3 13.4±3.9 0.02
DBP awake variability, mmHg 9.0±2.3 9.0±2.3 9.0±2.5 0.84
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Characteristics Overall population N=737 Calcification Score(≤3) N=660
Calcification Score
(≥4) N=77 P value
SBP asleep variability, mmHg 10.9±3.4 10.8±3.4 11.6±3.5 0.05
DBP asleep variability, mmHg 8.0±2.5 8.0±2.5 8.2±2.7 0.58
Normal BP dipping*, % 37% 38% 25% 0.03
*
= more than 10% decline in SBP from awake to asleep mean values
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